ARTICLE | Company News
MAXY, ITMN in interferon deal
September 5, 2001 7:00 AM UTC
Maxygen (MAXY) will develop second generation interferon gamma products for InterMune (ITMN), which will take the compounds into clinical development. Payments to MAXY, including upfront license fees,...